A detailed history of Vident Advisory, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Vident Advisory, LLC holds 387,116 shares of JNJ stock, worth $56.4 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
387,116
Previous 291,844 32.64%
Holding current value
$56.4 Million
Previous $45.7 Billion 33.87%
% of portfolio
1.28%
Previous 1.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $14.8 Million - $15.5 Million
95,272 Added 32.64%
387,116 $61.2 Billion
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $5.29 Million - $5.77 Million
36,320 Added 14.21%
291,844 $45.7 Billion
Q3 2023

Feb 21, 2024

SELL
$155.75 - $174.48 $5.66 Million - $6.34 Million
-36,320 Reduced 12.45%
255,524 $39.8 Billion
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $39.8 Million - $44.6 Million
255,524 New
255,524 $39.8 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.